Hum. Reprod. Advance Access originally published online on December 9, 2004
Human Reproduction 2005 20(3):649-656; doi:10.1093/humrep/deh648
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Reproduction Vol. 20 No. 3 © The Author 2004; all rights reserved
Urinary gonadotrophins but not recombinant gonadotrophins reduce expression of VEGF120 and its receptors flt-1 and flk-1 in the mouse uterus during the peri-implantation period
1 Division of Medical Pharmacology, Leiden Amsterdam Center for Drug Research/Leiden University Medical Center, Gorlaeus Laboratories, P.O. Box 9502, 2300 RA Leiden and 2 Department of Anatomy and Embryology and 3 Department of Gynaecology & Reproductive Medicine, Leiden University Medical Center, Leiden, The Netherlands
4 To whom correspondence should be addressed at: Division of Medical Pharmacology, LACDR/LUMC, Gorlaeus Laboratories, Leiden University, Postbus 9502, 2300 RA Leiden, The Netherlands. Email: r.sibug{at}lacdr.leidenuniv.nl
BACKGROUND: Ovarian stimulation in humans might affect the perinatal outcome and be considered as a stress factor in the implantation process. In this study we compared the effects of recombinant and urinary gonadotrophins during the mouse peri-implantation period. METHODS: Adult female CD1 mice were treated as follows (a) urinary hFSH and urinary hCG, (b) recombinant hFSH and recombinant hLH and (c) saline. The effects of the gonadotrophins on the expression of vascular endothelial growth factor120 (VEGF120) and its receptors and the corticotrophin releasing hormone (CRH) system during the peri-implantation period were studied. The specific effects of the different gonadotrophins on the onset of implantation were also studied. RESULTS: Urinary gonadotrophin treatment caused lower levels of VEGF120, flt-1 and flk-1 mRNA levels, reduced the size of the embryo implantation site, delayed implantation and prolonged the gestational period. Both urinary hFSH and urinary hCG contributed to the adverse effects. Levels of CRH and CRHR1 expression were not influenced. Recombinant gonadotrophin treatment did not alter any of the parameters studied. CONCLUSIONS: Our results show that the VEGF system of the mouse uterus during the peri-implantation period is adversely affected by urinary gonadotrophins but not by recombinant gonadotrophins. The CRH system was not affected by the two types of gonadotrophins.
Key words: CRH/peri-implantation period/recombinant gonadotrophins/urinary gonadotrophins/VEGF120
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R.M. Sibug, N. Datson, A.M.I. Tijssen, M. Morsink, J. de Koning, E.R. de Kloet, and F.M. Helmerhorst Effects of urinary and recombinant gonadotrophins on gene expression profiles during the murine peri-implantation period Hum. Reprod., January 1, 2007; 22(1): 75 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kapiteijn, C.S. de Bruijn, E. de Boer, A.J.M. de Craen, C.W. Burger, F.E. van Leeuwen, and F.M. Helmerhorst Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation? Hum. Reprod., December 1, 2006; 21(12): 3228 - 3234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Kelley, K. L. Kind, M. Lane, R. L. Robker, J. G. Thompson, and L. J. Edwards Recombinant human follicle-stimulating hormone alters maternal ovarian hormone concentrations and the uterus and perturbs fetal development in mice Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E761 - E770. [Abstract] [Full Text] [PDF]
|
|